On Tuesday, Clearmind Medicine Inc (NASDAQ:CMND) submitted three additional patent applications under the international Patent Cooperation Treaty (PCT) as part of its ongoing collaboration with SciSparc Ltd (NASDAQ:SPRC). The patent applications refer to novel proprietary compositions of 3,4-methylenedioxymethamphetamine (MDMA), Ibogaine, and Ketamine, each with Palmitoylethanolamide (PEA), the active ingredient of SciSparc’s proprietary CannAmide. These were previously filed as provisional pate
Credit repair brands agreed to pay $2.7 billion to settle allegations their telemarketing affiliates used phony real estate, rent-to-own advertisements.
Home invasion suspect captured in Smyth County 993thex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 993thex.com Daily Mail and Mail on Sunday newspapers.